Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults.
about
TB vaccine development and the End TB Strategy: importance and current status.Is immunosenescence influenced by our lifetime "dose" of exercise?Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals.Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes.The confounded effects of age and exposure history in response to influenza vaccinationCellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly.Association of CMV, HBV, or HCV co-infection with vaccine response in adults with well-controlled HIV infectionWhy CMV is a candidate for elimination and then eradication.The pathogenesis of human cytomegalovirus.Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic cell transplantation.Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status.Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade.Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio.Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses.The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose.CMV and natural killer cells: shaping the response to vaccination.Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.CMV immune evasion and manipulation of the immune system with aging.Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.Cytomegalovirus infection and progressive differentiation of effector-memory T cells
P2860
Q26748621-703EA161-57DB-451C-9BB9-D58505FF7DA4Q26749901-3243A504-29FA-415B-AFC0-5CB726D13CA6Q35560718-44CDCAE0-DE51-490F-A550-F5C2ECF39B86Q36180046-EC00DC3C-C10B-4672-9CD2-5B6EF7AEC8F7Q36495901-EBA69C11-A2F7-4C54-B149-A7D8D24F32BFQ36786132-C370FF5D-A7A2-4ABA-828F-A6531A9CEA15Q37131078-46BBC321-134D-44D1-9EE4-B20E6CA0EC9EQ37141395-74FBD3D6-172E-4FCE-B97C-768FF1F2B934Q38247785-FD19D7C3-ED71-459B-8FE1-95C61B2BD4B4Q38281851-01B84B44-312D-432C-AD6B-604591BB3591Q39310460-D667A4C4-CAA0-4EE3-A9EC-C3F556EBE171Q40104771-F3CF8749-F020-4D7A-AE77-DBBF369D2BB4Q40478812-DBA35563-45CF-4962-93AB-0BEBA33E8010Q40512629-5A16806D-5D46-4B03-A6A2-5B1F25938045Q40515774-CF8CA9A6-1708-43E3-B36C-6BDB37B7AB69Q40734674-97E505CD-6D80-4433-8727-BBC7A68AC090Q41928464-F590DB1A-1047-4778-9505-282D22FFF837Q45099647-77A3DBD3-EAB4-483C-887A-7EA74E915133Q47549093-B19B1D9D-1EA6-400B-B82C-23323BA3974BQ48273032-A6C214A4-BA76-4267-B692-E3CD2AA402A5Q49587964-43DB5D3E-A318-4A45-BD1B-925BE58BBCC8Q55459013-96CBAE38-E0F1-4578-AA92-0EE9D5AC3BF7Q55468883-577358B2-AD18-4C7E-9290-CD75B47384D1Q57821275-EE5E40DE-E033-45F3-8CE8-DB5CD75A0F6D
P2860
Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@ast
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@en
type
label
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@ast
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@en
prefLabel
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@ast
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@en
P2860
P356
P1476
Impact of human cytomegaloviru ...... nza vaccine in healthy adults.
@en
P2093
Amalia Magaret
Stacy Selke
P2860
P304
P356
10.1002/JMV.23642
P577
2013-09-01T00:00:00Z